Delivery Order SPE2DR25D2100-SPE2DR26FA1MK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,954.23 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-unit packages) on January 27, 2026, with completion expected by January 28, 2026. This non-competitive, firm fixed-price delivery order was fulfilled from the company's place of performance in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $28.6K to Amerisourcebergen Drug Corp for the supply of Vemlidy 25mg tablets (30-count) with a firm fixed-price structure. The award, issued on January 14, 2026, is scheduled for completion by February 11, 2026, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This competitive, non-set-aside contract represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $3,126.96 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on January 27, 2026, with an ultimate completion date of January 28, 2026. This firm fixed-price contract was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order valued at $7,602.53 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on January 14, 2026, with an ultimate completion date of January 15, 2026. This non-set-aside, firm fixed-price contract was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $4,700.52 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,892.71 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on January 23, 2026, with completion scheduled for January 26, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a task order issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $9,749.13 to AmerSourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on January 13, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price, non-set-aside contract is performed at the awardee's location in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerSourceBergen Drug Corp's parent company, Cencora, Inc.'s, larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $5,961.42 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on November 13, 2025, with an ultimate completion date of November 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $3,126.96 delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on January 28, 2026, with an ultimate completion date of January 29, 2026. This firm fixed-price contract, which carries no set-aside designation, will be performed at the awardee's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $9,945.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 10, 2025, with completion scheduled for July 11, 2025. This non-set-aside competitive award is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DR25D2100Indefinite Delivery Contract
- SPE2DR25D2100-SPE2DR26FA1MKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,194.29 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on January 28, 2026, with completion targeted for January 29, 2026. This firm fixed-price, non-set-aside contract is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company competes on a full and open basis for federal contracts and maintains a comprehensive portfolio of delivery orders covering a wide range of pharmaceutical products across multiple therapeutic domains. This specific delivery order for Vemlidy, an antiviral medication, exemplifies the company's role in supplying essential prescription medications to Department of Defense healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 1/27/26 |